Cardiovascular Systems EBIT

Cardiovascular Systems (CSII) currently reports a EBIT of $-39M as of December 2022. That compares with $-27M in the prior-year period — down 41.6% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Cardiovascular Systems's EBIT history and peer comparisons.

Cardiovascular Systems's EBIT decreased from $-27M to $-39M — a 41.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cardiovascular Systems's EBIT of $-39M is lower than the Healthcare sector average of $22B. That is roughly 100.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cardiovascular Systems reported $-39M in EBIT as of December 2022. That compares with $-27M in the prior-year period — down 41.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-39M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Cardiovascular Systems, and consider following CSII for alerts when major investors trade the stock.